Uncategorized
Speaker: Standardized definitions, endpoints should drive cross-linking trials
As clinical trials for corneal collagen cross-linking proceed, clinicians should use standardized definitions and metrics to evaluate the effectiveness of treatment, according to a speaker at the World Cornea Congress in San Diego.“If we’re going to say that cross-linking prevents progression, we need to measure progression,” Penny A. Asbell, MD, FACS, MBA, OSN Contact Lenses Section Editor, told Ocular Surgery News in a subsequent interview. “The key issues for treatment of keratoconus are prevention of progression and improvement of best corrected spectacle vision. Those are the endpoints that we typically (Read more...)